Josef von Rickenbach

Josef von Rickenbach is an accomplished executive with extensive experience in the life sciences and biotechnology sectors. Currently serving as Director at Javara and holding key leadership roles as Chairman of the Board of Directors at ZAGENO Inc. and Aileron Therapeutics, as well as Managing Director at stet vision LLC, Josef von Rickenbach also has a history of significant contributions as CEO and Co-Founder of Helio Vision, Inc., which was acquired by Aldeyra Therapeutics in 2019. Notably, Josef von Rickenbach co-founded and led PAREXEL as Chairman and CEO from 1982 until 2018. Educational credentials include an MBA from Harvard Business School and a B.A. in Business Economics from the University of Lucerne.